Franklin Biolabs, LLC
Philadelphia, PA Research Vector
- UEI
- G79EN8G1JD21
- CAGE
- 0Q9H7
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 1831 Delancey Pl, Philadelphia, PA 19103, USA
- Website
- franklinbio.com
- Founded
- 2022
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $35,363 |
Contract awards
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| The Children's Hospital Of Philadelphia | U01TR005355 | $178,302 | |
| The Trustees Of The University Of Pennsylvania | U01NS134672 | $1,150,290 | |
| The Children's Hospital Of Philadelphia | U01TR005355 | $100,125 | |
| The Children's Hospital Of Philadelphia | U01TR005355 | $385,985 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Vector Biolabs | Malvern, PA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Addgene Inc. | Watertown, MA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Vectorbuilder Inc. | Chicago, IL | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Vector Biomed Inc. | Gaithersburg, MD | 325414 Biological Product (except Diagnostic) Manufacturing |
| Emmune Inc. | Cambridge, MA | — |
About the company
Franklin Biolabs, LLC Research Vector Division, a for-profit organization headquartered in Philadelphia, Pennsylvania, delivers gene therapy vector manufacturing, AAV (adeno-associated virus) production and scale-up, and preclinical GLP toxicology and biodistribution studies to the National Institutes of Health as a prime contractor on small purchase orders and as a sub-recipient on federal research grants.
The vendor's recent federal footprint is dominated by NIH sub-award work. Franklin Biolabs operates as a sub-recipient on two grants awarded by The Children's Hospital of Philadelphia and one by The Trustees of The University of Pennsylvania, performing GLP-compliant rodent and nonhuman primate toxicology studies, AAV manufacturing at multiple scales (10L and 200L suspension reactors), potency assay development, and manufacturability assessments in support of gene therapy and lipid nanoparticle (LNP) research programs. On the prime side, Franklin Biolabs holds two direct purchase orders from NIH institutes: a $22,890.80 firm fixed-price contract from the National Institute of Child Health and Human Development awarded January 22, 2025, for gene therapy vector services (ultimate completion January 21, 2026), and a $12,472.30 firm fixed-price contract from the National Institute of Neurological Disorders and Stroke awarded August 20, 2025, for immune safety monitoring of clinical trial participants (ultimate completion August 19, 2026). All five awards in the source carry full-and-open (no set-aside) designations.
The vendor's customer base is entirely concentrated within HHS NIH — 100% of recorded awards fund NIH programs across the Neurological Disorders and Stroke institute, the Child Health and Human Development institute, and the Office of the Director. Combined potential value across all awards stands at $35 thousand, though reported obligations total $1.7 million, indicating that the vendor's actual invoiced revenue substantially exceeds the ceiling values on these purchase orders. Award frequency has slowed to one grant sub-award in the first half of 2026 after four awards in 2025. One award (the $12.5 thousand NINDS contract) faces recompete exposure within the next twenty-four months.
Quick answers
Is Franklin Biolabs, LLC registered in SAM.gov?
Yes. Franklin Biolabs, LLC's SAM.gov registration is active through December 9, 2026.
How much has Franklin Biolabs, LLC received in federal contracts?
Federal contracts obligated $35,363 to Franklin Biolabs, LLC in fiscal year 2025.
How does Franklin Biolabs, LLC rank among federal contractors?
Franklin Biolabs, LLC ranked #95 in NAICS 325414 in FY2025.
What is Franklin Biolabs, LLC's most recent federal award?
Franklin Biolabs, LLC's most recent federal contract award is This is a request for immune safety monitoring for clinical trial participants enrolled in the institutes protocol (75N95A25P00109), from National Institute of Neurological Disorders and Stroke (NIH), on August 20, 2025.
On GovTribe
See Franklin Biolabs, LLC's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors